C. Herrmann

11.5k total citations · 1 hit paper
51 papers, 1.5k citations indexed

About

C. Herrmann is a scholar working on Neurology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, C. Herrmann has authored 51 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Neurology, 13 papers in Oncology and 9 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in C. Herrmann's work include Myasthenia Gravis and Thymoma (21 papers), Pituitary Gland Disorders and Treatments (8 papers) and Global Cancer Incidence and Screening (6 papers). C. Herrmann is often cited by papers focused on Myasthenia Gravis and Thymoma (21 papers), Pituitary Gland Disorders and Treatments (8 papers) and Global Cancer Incidence and Screening (6 papers). C. Herrmann collaborates with scholars based in Switzerland, United States and Germany. C. Herrmann's co-authors include Donald G. Mulder, Faramarz Naeim, Dieter Fritze, Thomas Cerny, Harald Frick, Sabine Schmid, Karl Heinimann, Aurelius Omlin, R. L. Walford and Gerald D. Buckberg and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Neurology.

In The Last Decade

C. Herrmann

50 papers receiving 1.4k citations

Hit Papers

Multiple primary tumours: challenges and approaches, a re... 2017 2026 2020 2023 2017 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Herrmann Switzerland 19 446 433 404 403 263 51 1.5k
H. Ekert Australia 23 117 0.3× 248 0.6× 395 1.0× 173 0.4× 206 0.8× 136 2.3k
Toivo T. Salmi Finland 25 167 0.4× 269 0.6× 194 0.5× 341 0.8× 75 0.3× 64 1.6k
Henry Miller United Kingdom 22 389 0.9× 176 0.4× 70 0.2× 269 0.7× 560 2.1× 81 1.6k
Janet R. Williams Australia 21 151 0.3× 222 0.5× 234 0.6× 279 0.7× 44 0.2× 58 1.3k
Denis R. Benjamin United States 26 90 0.2× 236 0.5× 559 1.4× 282 0.7× 109 0.4× 62 1.8k
Irving I. Kessler United States 24 235 0.5× 453 1.0× 72 0.2× 476 1.2× 77 0.3× 35 1.7k
Nicola Ragni Italy 41 123 0.3× 360 0.8× 103 0.3× 303 0.8× 245 0.9× 171 4.6k
Shayna Zelcer Canada 22 260 0.6× 175 0.4× 168 0.4× 220 0.5× 140 0.5× 68 1.4k
Terry Harville United States 13 141 0.3× 186 0.4× 221 0.5× 383 1.0× 57 0.2× 29 1.9k
Jerry Stein Israel 27 142 0.3× 298 0.7× 177 0.4× 185 0.5× 89 0.3× 119 2.3k

Countries citing papers authored by C. Herrmann

Since Specialization
Citations

This map shows the geographic impact of C. Herrmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Herrmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Herrmann more than expected).

Fields of papers citing papers by C. Herrmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Herrmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Herrmann. The network helps show where C. Herrmann may publish in the future.

Co-authorship network of co-authors of C. Herrmann

This figure shows the co-authorship network connecting the top 25 collaborators of C. Herrmann. A scholar is included among the top collaborators of C. Herrmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Herrmann. C. Herrmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kalafat, Erkan, et al.. (2023). Prognostic value of angiogenic markers in pregnancy with fetal growth restriction. Ultrasound in Obstetrics and Gynecology. 63(5). 619–626. 2 indexed citations
2.
Thong, Melissa S. Y., Eva Martin‐Diener, Bertrand Camey, et al.. (2021). Identifying classes of the pain, fatigue, and depression symptom cluster in long-term prostate cancer survivors—results from the multi-regional Prostate Cancer Survivorship Study in Switzerland (PROCAS). Supportive Care in Cancer. 29(11). 6259–6269. 18 indexed citations
3.
Herrmann, C., et al.. (2021). Screening is associated with lower mastectomy rates in eastern Switzerland beyond stage effects. BMC Cancer. 21(1). 229–229. 5 indexed citations
4.
Schulze, Martin, Ulrike Jakop, C. Herrmann, et al.. (2020). Antibacterial defense in bull and boar semen: A putative link to the microbiome and reproductive strategy?. Theriogenology. 157. 335–340. 12 indexed citations
5.
Martin‐Diener, Eva, Bertrand Camey, Isabelle Konzelmann, et al.. (2020). Health‐related quality of life in long‐term prostate cancer survivors after nerve‐sparing and non‐nerve‐sparing radical prostatectomy—Results from the multiregional PROCAS study. Cancer Medicine. 9(15). 5416–5424. 5 indexed citations
6.
Feller, Anita, Katarina L. Matthes, Andrea Bordoni, et al.. (2020). The relative risk of second primary cancers in Switzerland: a population-based retrospective cohort study. BMC Cancer. 20(1). 51–51. 41 indexed citations
7.
Herrmann, C., S.M. Ess, Harald Frick, et al.. (2019). Regional differences and trends in breast cancer surgical procedures and their relation to socioeconomic disparities and screening patterns. Journal of Public Health. 28(1). 71–80. 1 indexed citations
8.
Botta, Laura, Riccardo Capocaccia, Annalisa Trama, et al.. (2018). Bayesian estimates of the incidence of rare cancers in Europe. Cancer Epidemiology. 54. 95–100. 7 indexed citations
9.
Ess, S.M., C. Herrmann, Christine Bouchardy, et al.. (2018). Impact of subtypes and comorbidities on breast cancer relapse and survival in population-based studies. The Breast. 41. 151–158. 14 indexed citations
10.
Herrmann, C., Penelope Vounatsou, Beat Thürlimann, et al.. (2018). Impact of mammography screening programmes on breast cancer mortality in Switzerland, a country with different regional screening policies. BMJ Open. 8(3). e017806–e017806. 18 indexed citations
11.
Schmid, Sabine, Karl Heinimann, Harald Frick, et al.. (2017). Multiple primary tumours: challenges and approaches, a review. ESMO Open. 2(2). e000172–e000172. 342 indexed citations breakdown →
12.
Herrmann, C., S.M. Ess, Beat Thürlimann, Nicole Probst‐Hensch, & Penelope Vounatsou. (2015). 40 years of progress in female cancer death risk: a Bayesian spatio-temporal mapping analysis in Switzerland. BMC Cancer. 15(1). 666–666. 12 indexed citations
13.
Herrmann, C., Thomas Cerny, Penelope Vounatsou, et al.. (2013). Cancer survivors in Switzerland: a rapidly growing population to care for. BMC Cancer. 13(1). 287–287. 26 indexed citations
14.
Borrmann, M., et al.. (2004). Erfahrungen und Schwierigkeiten bei der Implementierung von Impfregistern in Sachsen-Anhalt. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 47(12). 1189–1195. 4 indexed citations
16.
Nimmich, Wolfgang, et al.. (1979). [Common antigen for serological detection of urinary tract infections during pregnancy (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 101(23). 1489–94. 1 indexed citations
17.
Naeim, Faramarz, et al.. (1978). Association of HLA—B8, DRw3, and Anti‐Acetylcholine Receptor Antibodies in Myasthenia Gravis. Tissue Antigens. 12(5). 381–386. 52 indexed citations
18.
Herrmann, C., et al.. (1977). The problem of serological reactions for detecting foreign proteins in heated meat products.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 31(2). 153–5. 1 indexed citations
19.
Fritze, Dieter, et al.. (1973). HL-A TYPES IN MYASTHENIA GRAVIS. The Lancet. 302(7822). 211–211. 21 indexed citations
20.
Merritt, H. Houston, Gilbert H. Glaser, & C. Herrmann. (1954). A STUDY OF THE SHORT‐ AND LONG‐TERM EFFECTS OF ADRENAL STEROIDS ON THE CLINICAL PATTERNS OF MULTIPLE SCLEROSIS. Annals of the New York Academy of Sciences. 58(5). 625–632. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026